NSETrading Window26 Jun 2026 · 26 Jun 2026, 06:34 pm
Trading Window
Eris Lifesciences Limited · ERIS
✦ AI SummaryRegulatory
Eris Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed for all Designated Persons and their immediate relatives from July 01, 2026, and will remain closed till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ending on June 30, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
ERIS_26062026183415_TWCsigned.pdf
View document text
Date: July 27, 2017
Mr...
Date: 26 June 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza Bandra Kurla Complex
Dalal Street Bandra (E)
Mumbai - 400001 Mumbai - 400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF CLOSURE OF TRADING WINDOW
Dear Sir/Madam,
In terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance
with the terms of Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons
and immediate relatives of Designated Persons of the Company', the "Trading Window" for dealing in
the securities of the Company will be closed for all Designated Persons and their immediate relatives
from July 01, 2026, and the same will remain closed till 48 hours after the declaration of Unaudited
Financial Results of the Company for the quarter ending on June 30, 2026, to the public.
Accordingly, all Designated Persons and their immediate relatives of the Company are advised not to
trade in the securities of the Company during the aforesaid period of Closure of Trading Window.
This trading window closure notice operates independently and does not intend to amend, alter,
modify, curtail, or extend any other notice(s) on the closure of trading window, if any, for any other
purpose, whether currently in effect or to be issued during the validity of this notice.
Kindly take note the same.
Thanking you,
Yours sincerely
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary and Compliance Officer
Mem. No. A26493